---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015455"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2024-04-22T23:59:59+00:00"
generated_at: "2026-06-03T14:12:49.977098+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Celularity receives Nasdaq delisting notice for late 10-K filing; must submit plan by June 17

## Summary
- Failed to file 2023 Form 10-K by April 15 extension; Nasdaq notified on April 17, 2024.
- Common stock (CELU) and warrants (CELUW) continue trading; no immediate delisting.
- Must submit compliance plan within 60 days (by June 17, 2024); if accepted, cure by Oct 14, 2024.
- No assurance of regaining compliance; delisting possible if plan not accepted or cure fails.

## SEC filing metadata
- accession: 0001493152-24-015455
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2024-04-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315224015455/0001493152-24-015455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315224015455/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015455
- JSON: https://secwatch.observer/filing/0001493152-24-015455.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015455.txt

## Key facts
- Listing & Compliance Notices
  Celularity Inc received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: April 17, 2024, Celularity informed the Listing Qualifications department of the Nasdaq Stock Market LLC, or Nasdaq, that it failed to timely file its 2023 Form 10-K within the extension period provided by Rule 12b-25 because Celularity had not yet completed the preparation of the financial statements for the year ended December 31, 2023. On April 17, 2024, Nasdaq provided formal notice to Celularity that as a result of Celularity’s failure to timely file its 2023 Form 10-K, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000149315224015455/0001493152-24-015455-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.